Welcome to learn about our company
Leave Your Message
Welcome to learn about our company
Gynostemma pentaphyllum, commonly known as Jiaogulan or "Southern Ginseng," has rapidly transitioned from a traditional herbal remedy to a highly sought-after raw material in the global pharmaceutical industry. Rich in structurally diverse triterpenoid saponins known as gypenosides, Gynostemma extract offers a unique pharmacological profile that closely mirrors, and in some cases surpasses, that of Panax Ginseng. For pharmaceutical companies seeking to develop innovative therapeutics, metabolic regulators, and cardioprotective formulations, Gynostemma extract represents a versatile, highly bioavailable, and economically viable active pharmaceutical ingredient (API) source.
Industrial Insight: The pharmacological efficacy of Gynostemma extract is primarily driven by its high concentration of Gypenosides, several of which are identical to ginsenosides (such as Rb1, Rd, Rc, and Rg3). This chemical synergy makes it an invaluable asset for targeting complex, multi-pathway diseases like metabolic syndrome and chronic inflammation.
The global pharmaceutical market is currently experiencing a significant paradigm shift toward natural product-derived drugs and standardized botanical extracts. Gynostemma extract is positioning itself at the forefront of this movement. Historically utilized in dietary supplements, the extraction of high-purity gypenosides (ranging from 80% to 98% by HPLC) has opened new doors for prescription drug development and clinical research. Today, pharmaceutical companies are incorporating these purified fractions into formulations targeting cardiovascular health, type 2 diabetes management, and immunological support.
From a supply chain perspective, China remains the primary global hub for Gynostemma cultivation and processing, owing to its optimal climatic conditions in the mountainous southern regions. Industrial-scale cultivation under Good Agricultural and Collection Practices (GACP) ensures that modern extraction facilities receive a consistent, pesticide-free, and heavy-metal-compliant raw botanical supply. This stability in the upstream supply chain is critical for pharmaceutical manufacturers who require long-term consistency and batch-to-batch uniformity to meet stringent regulatory approvals (such as FDA NDIs, EFSA Novel Food statuses, and various national pharmacopoeia standards).
Cardiovascular diseases (CVD) remain a leading cause of global mortality. Gynostemma extract has demonstrated profound endothelial protective properties. The active gypenosides stimulate the release of nitric oxide (NO) in vascular endothelial cells, promoting vasodilation, improving arterial elasticity, and reducing blood pressure. Furthermore, clinical trials and pharmacological studies indicate that Gynostemma extract aids in modulating lipid profiles by lowering low-density lipoprotein cholesterol (LDL-C) and triglycerides while raising high-density lipoprotein cholesterol (HDL-C), making it a potent candidate for anti-atherosclerotic drug development.
One of the most promising applications of Gynostemma extract in modern medicine is its role as a natural AMPK (AMP-activated protein kinase) activator. AMPK is the master regulator of energy metabolism in the human body. By activating this pathway, Gynostemma extract enhances insulin sensitivity, promotes glucose uptake in skeletal muscle tissues, and suppresses hepatic gluconeogenesis. Pharmaceutical companies are actively researching Gynostemma-derived saponins as adjunct therapies alongside metformin or as standalone natural therapeutics to combat insulin resistance and obesity-related metabolic disorders.
With an aging global population, the demand for neuroprotective drugs is soaring. Gynostemma extract exhibits potent antioxidant and anti-apoptotic effects on neuronal cells. By scavenging reactive oxygen species (ROS) and modulating neuroinflammatory pathways (specifically inhibiting NF-kB activation), Gypenosides protect dopaminergic and hippocampal neurons from degeneration. This positioning makes Gynostemma extract an attractive lead compound for developing treatments targeting Parkinson's disease, Alzheimer's disease, and general cognitive decline.
In oncology, Gynostemma extract is being explored for its immunomodulatory properties and its ability to mitigate the side effects of chemotherapy and radiotherapy. The polysaccharides and saponins present in Gynostemma stimulate the proliferation and activity of natural killer (NK) cells, T-lymphocytes, and macrophages. When used as an adjuvant, it helps rebuild the immune system of compromised patients, reduces chemotherapy-induced fatigue, and exhibits direct anti-proliferative effects on certain cancer cell lines by inducing cell cycle arrest and apoptosis.
A modern plant extract factory is a high-tech enterprise that integrates scientific research, production, and quality control, specializing in isolating and purifying specific bioactive compounds from natural botanicals. Guided by the core philosophy of "Natural, Safe, and Effective," we combine traditional herbal wisdom with modern fine chemical engineering and biotechnology, committed to providing standardized, high-quality raw materials for the global pharmaceutical, nutraceutical, functional food, cosmetic, and animal feed industries.
The factory typically possesses a complete industrial chain from raw material pretreatment to finished product packaging. The production process strictly adheres to international standards such as GMP (Good Manufacturing Practice), ensuring cleanliness, controllability, and traceability at every stage.
Focuses on optimizing extraction processes, developing new components, and formulating studies to ensure the highest purity of active ingredients like Gypenosides.
Equipped with advanced facilities like multi-functional extraction tanks, chromatographic separation systems, membrane filtration, and spray drying towers.
Equipped with precision instruments such as HPLC and GC-MS to conduct comprehensive testing on raw materials, intermediates, and finished products.
"In essence, we are more than a simple processing workshop; we are a technology-driven 'provider of natural ingredient solutions,' ensuring that every batch of product has consistent chemical composition and reliable bioactivity."
We employ modern techniques such as Supercritical Fluid Extraction, Membrane Separation Technology, and Column Chromatography Purification. Compared to traditional methods like decoction and alcohol precipitation, these technologies offer higher selectivity, lower solvent residues, and better protection for heat-sensitive components. For instance, supercritical CO₂ extraction ensures a solvent-free final product, making it ideal for high-value essential oils and sensitive compounds. Advanced equipment is the fundamental guarantee for achieving high purity and high yield.
Quality is built through control. Our quality system covers the entire process from "seed to finished product":
• Raw Material Control: Incoming botanical materials are subjected to species identification, pesticide residue, and heavy metal testing to ensure safety from the start.
• In-Process Control: Key process parameters (e.g., temperature, pressure, concentration) are monitored in real-time at Critical Control Points (CCPs) to ensure process stability.
• Finished Product Control: Every batch of finished product undergoes rigorous testing to ensure active ingredient content and impurity limits (e.g., heavy metals, microorganisms) comply with client specifications and international pharmacopoeia standards such as USP and EP.
A strong R&D team can conduct customized development based on clients' specific requirements such as compound content, solubility, and dosage form needs. Whether optimizing the extraction process of an existing product or developing novel components from new botanical sources, we provide full technical support from lab-scale trials to industrial-scale production. This flexibility makes us a reliable partner for clients on their innovation journey.
With automated production lines and standardized operating procedures, we possess large-scale, continuous production capacity. This enables effective cost control and guarantees timely order fulfillment and long-term, stable product supply. The ability to provide stable bulk supply is crucial for large domestic and international manufacturers and is key to gaining market trust.
We have established a product traceability system. Using a unique batch number, one can trace the product's origin, production batch, test reports, and logistics information. This facilitates rapid traceability and recall in case of quality issues and, more importantly, enhances client confidence in product transparency and safety.
In summary, the core advantage of Andy Biotech lies in the integration of technology, quality, and systems to transform nature's gifts into safe, effective, and standardized industrial products. This creates value for our clients and safeguards the health of end-consumers.
